Shell plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Shell plc (incorporated in England and Wales) covers share repurchase transactions executed between November 1, 2024, and November 29, 2024. The report was filed on December 2, 2024. The transactions relate to the Company's ongoing share buy-back programme announced on October 31, 2024, which includes both on-market and off-market limbs.
Key Financial Metrics: Share Repurchases
The filing details daily purchases of Shell shares for cancellation across multiple trading venues, primarily the London Stock Exchange (LSE) in GBP and Euronext Amsterdam (XAMS) in EUR. Citigroup Global Markets Limited executed these trades independently under pre-set parameters.
| Date | Venue | Currency | Shares Purchased | VWAP (Volume Weighted Avg Price) |
|---|---|---|---|---|
| Nov 01 | LSE / XAMS | GBP / EUR | 1,465,000 | £25.98 / €31.28 |
| Nov 04 | LSE / XAMS | GBP / EUR | 1,867,500 | £26.05 / €31.33 |
| Nov 05 | LSE / XAMS | GBP / EUR | 1,787,450 | £26.02 / €31.34 |
| Nov 06 | LSE / XAMS | GBP / EUR | 1,753,000 | £25.93 / €31.44 |
| Nov 07 | LSE / XAMS | GBP / EUR | 1,710,291 | £26.13 / €31.72 |
| Nov 08 | LSE / XAMS | GBP / EUR | 1,815,000 | £25.78 / €31.35 |
| Nov 11 | LSE / XAMS | GBP / EUR | 1,363,000 | £25.61 / €31.31 |
| Nov 12 | LSE / XAMS | GBP / EUR | 947,000 | £25.32 / €30.89 |
| Nov 13 | LSE / XAMS | GBP / EUR | 123,000 | £25.18 / €30.61 |
| Nov 14 | LSE / BATS / XAMS / CBOE | GBP / EUR | 3,565,144 | £25.33 / €30.83 |
| Nov 15 | LSE / BATS / XAMS | GBP / EUR | 2,877,100 | £25.60 / €31.05 |
| Nov 18 | LSE / XAMS | GBP / EUR | 2,000,000 | £25.76 / €31.15 |
| Nov 19 | LSE / XAMS | GBP / EUR | 2,150,000 | £25.79 / €31.17 |
| Nov 20 | LSE / XAMS | GBP / EUR | 1,909,000 | £25.60 / €31.09 |
| Nov 21 | LSE / XAMS | GBP / EUR | 1,550,000 | £25.81 / €31.30 |
| Nov 22 | LSE / XAMS | GBP / EUR | 1,673,000 | £26.05 / €31.61 |
| Nov 25 | LSE / XAMS | GBP / EUR | 2,000,000 | £25.94 / €31.36 |
| Nov 26 | LSE / XAMS | GBP / EUR | 2,267,000 | £25.61 / €30.93 |
| Nov 27 | LSE / XAMS | GBP / EUR | 2,120,000 | £25.42 / €30.74 |
| Nov 28 | LSE / XAMS | GBP / EUR | 1,776,100 | £25.30 / €30.65 |
| Nov 29 | LSE / XAMS | GBP / EUR | 2,080,000 | £25.33 / €30.71 |
Note: Total shares purchased across all dates and venues in this filing exceed 35 million shares. The filing does not provide a consolidated total monetary value or aggregate cash flow impact for the period.
Material Changes and Program Details
The share purchases are part of a programme authorized by shareholders, running from October 31, 2024, through January 24, 2025. The programme is conducted in compliance with Chapter 9 of the UK Listing Rules and the Market Abuse Regulation (EU MAR and UK MAR). Trading was executed by Citigroup Global Markets Limited within pre-set parameters. No material changes to the company's core business operations or financial position (revenue, profit, debt) are disclosed in this specific filing, as it focuses solely on capital return activities.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the regulatory compliance statements regarding the buy-back programme. The primary contingency noted is the adherence to regulatory limits and parameters set for the buy-back period ending January 24, 2025.
Key Facts for Investor Verification
- Programme Duration: Verify the remaining capacity and timeline of the buy-back programme, which concludes on January 24, 2025.
- Total Repurchase Volume: Confirm the aggregate number of shares repurchased and cancelled against the total authorization limit approved by shareholders.
- Capital Allocation: Assess the impact of these repurchases on the company's net debt and liquidity position, as this filing does not disclose the total cash outflow.
- Share Count: Verify the updated total number of issued shares following the cancellation of the shares purchased in November 2024.
- Regulatory Compliance: Ensure all trades were executed within the "on-market" and "off-market" limbs as defined by UK and EU Market Abuse Regulations.